Which specialty should a patient with a vulvar mass be referred to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Referral Specialty for Vulvar Mass

A patient with a vulvar mass should be referred to gynecologic oncology for evaluation and management. 1, 2

Primary Referral Pathway

  • Gynecologic oncology is the appropriate specialty for any vulvar mass requiring evaluation, as vulvar cancer accounts for 5–8% of gynecologic malignancies and requires specialized surgical and oncologic expertise 1

  • The NCCN guidelines for vulvar cancer management are developed and implemented by gynecologic oncologists, establishing this specialty as the standard of care for vulvar neoplasms 1

  • Diagnostic delays of approximately 2 years are common when vulvar masses are initially managed as inflammatory conditions rather than promptly referred for oncologic evaluation 2, 3

Why Gynecologic Oncology Specifically

  • Vulvar malignancies require specialized surgical expertise using standardized anatomic landmarks and techniques (partial/total vulvectomy, superficial/deep excision, inguinofemoral lymphadenectomy) that are within the scope of gynecologic oncology training 4

  • Most vulvar neoplasias are diagnosed at early stages when surgical management by a gynecologic oncologist offers the best outcomes 1

  • Squamous cell carcinoma represents the vast majority of vulvar cancers, but rarer histologies (melanoma, extramammary Paget's disease, Bartholin gland adenocarcinoma, verrucous carcinoma, basal cell carcinoma, sarcoma) also require gynecologic oncology expertise 1

Critical Pitfalls to Avoid

  • Do not delay referral by attempting prolonged empiric treatment for presumed inflammatory conditions; any persistent vulvar mass warrants gynecologic oncology evaluation 2, 3

  • Do not assume age protects against malignancy—while vulvar cancer was historically considered a postmenopausal disease, younger premenopausal women are increasingly affected due to HPV infection 3

  • Biopsy suspicious lesions before referral if you have the expertise, but do not delay referral waiting for biopsy results; gynecologic oncology can perform diagnostic biopsy as part of initial evaluation 3, 5

When Dermatology May Be Involved

  • Dermatologists may participate in the initial evaluation of vulvar lesions and should be familiar with characteristic findings of vulvar malignancies to ensure appropriate referral 2

  • However, definitive management remains with gynecologic oncology once a vulvar mass is identified 1, 2

Special Considerations for Benign Conditions

  • If the vulvar mass is ultimately determined to be a benign inflammatory condition (lichen sclerosus, lichen planus, vulvodynia), ongoing management may involve gynecology or dermatology with vulvar expertise 6

  • Lichen sclerosus carries a 4–7% lifetime risk of progression to vulvar squamous cell carcinoma and requires long-term surveillance, which can be coordinated between gynecology and dermatology 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and management of vulvar cancer: A review.

Journal of the American Academy of Dermatology, 2019

Research

Gynecologic Cancers: Vulvar Cancer.

FP essentials, 2025

Guideline

Evidence‑Based Management of Common Vulvar Conditions in Postmenopausal Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.